Roche Holdings ADR logo

Roche Holdings ADR

Stock
Stock
Ticker: RHHBY
RHHBY

Price

Price

CHART BY

Historical dividends and forecast

All dividend data

Roche Holdings ADR has so far distributed $1.55 in 2026. The next dividend will be paid on 22.04.2027


$1.168

CHART BY

Frequently asked questions

The market capitalization of Roche Holdings ADR is $290.70B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
The Price-to-Earnings (P/E) ratio (TTM) for Roche Holdings ADR is 21.58. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
Roche Holdings ADR's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $2.987. EPS indicates the company's profitability on a per-share basis.
Currently, 24 analysts cover Roche Holdings ADR's stock, with a consensus target price of $70.61. Analyst ratings provide insights into the stock's expected performance.
Over the trailing twelve months, Roche Holdings ADR reported a revenue of $93.82B.
Roche Holdings ADR's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $34.00B. EBITDA measures the company's overall financial performance.
Roche Holdings ADR has a free cash flow of $23.23B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
Roche Holdings ADR employs approximately 112,774 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.
The free float of Roche Holdings ADR is 5.51B. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$290.70B
EPS (TTM) 
$2.987
Free Float 
5.51B
P/E ratio (TTM) 
21.58
Revenue (TTM) 
$93.82B
EBITDA (TTM) 
$34.00B
Free Cashflow (TTM) 
$23.23B

Pricing

1D span
$54.27$55.11
52W span
$39.01$60.64

Analyst Ratings

The price target is $70.61 and the stock is covered by 24 analysts.

Buy

13

Hold

9

Sell

2

Information

Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. The Roche Pharmaceutical division comprises the business segments, such as Roche Pharmaceuticals and Chuga. The Diagnostic division consists of the following four business areas: centralized and point of care solutions, molecular diagnostics, tissue diagnostics, and diabetes care. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Employees
112,774
Industries
Major Pharmaceuticals
Sector
Health Care

Identifier

Primary Ticker
RHHBY

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation